Description
This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications for implementation of investigator-initiated, non-high-risk clinical trials. The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/). Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (R01) Grant application.
Document Type: Grants Notice
Funding Opportunity Number: PAR-13-149
Posted Date: Mar 22, 2013
Current Closing Date for Applications: Jan 13, 2016
Category of Funding Activity: Health
CFDA Number(s):
93.855 -- Allergy, Immunology and Transplantation Research
93.856 -- Microbiology and Infectious Diseases Research
Eligible Applicants
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Agency Name
Link to Additional Information
http://grants.nih.gov/grants/guide/pa-files/PAR-13-149.html
